| CCC | I310 |
The SHI-1 cell line is a human acute myeloid leukemia (AML) cell line that is commonly used in cancer research, particularly in studies related to hematologic malignancies. AML is a type of cancer that affects the bone marrow and blood, leading to the rapid growth of abnormal white blood cells. The SHI-1 cell line was derived from the bone marrow of a patient with AML and has been extensively characterized to study the biology and behavior of this aggressive disease.
The SHI-1 cell line serves as a valuable tool for studying AML and has significantly contributed to our understanding of the molecular and cellular processes underlying this complex disease. Its use has led to important discoveries in leukemia research and has the potential to inform the development of novel therapeutic approaches for AML patients in the future.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI310Hu11 | Human SHI-1 Acute Monocytic Leukemia Cells (SHI-1) | For research use only. It is not approved for human or animal use, or for applications in in vitro diganostic procedures. |
| Extracts | n/a | Extract of SHI-1 Acute Monocytic Leukemia Cells (SHI-1) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | MSI310Hu11 | Medium for Human SHI-1 Acute Monocytic Leukemia Cells (SHI-1) | Complete Medium for the culture of SHI-1 cell line |